This report, COVID-19 Testing Market Update, 2022, provides market sizing and estimates for COVID-19 tests with some discussion of market impacts of COVID-19. The scourge of COVID-19 continued to occupy laboratories and the in vitro diagnostic (IVD) companies that serve them throughout 2021 and into 2022. Testing already present in large labs and clinics entered the home last year, which added to market revenues.
There was 33 BN of revenues in 2021, and the report details the share of antigen, PCR and antibody testing, as well as point of care tests. Forecasts are provided in the report, though there is a lack of consensus on exact forecasting. At the time of publication, there is a slight decrease in cases which might suggest a decrease in COVID-19 testing revenues, but we’ve been through this before.
COVID-19 Testing Market Update, 2022 covers these topics, trends, and predictions, in addition to providing other essential market analysis.
As part of it’s analysis the report provides: segmentation and breakout, company market share, trends, products on the market and recent test innovations.